NCT00936247

Tetraspan 6 Percent (%) Combined With Sterofundin ISO Versus Albumin 5 Percent (%) Combined With Sodium Chloride (NaCL)

Prospective, Controlled, Single-blind, Bicentric, Randomized Study on the Safety of HES 130/0.42 Combined With a Bal. Electr. Sol. vs 5% Albumin Comb. With an Unbal. Electr. Sol. (NaCl 0.9%) in Pat. With Compensated Renal Failure

• Status: Terminated
• Phase: Phase 4
• Study type: Interventional
• Enrollment: 2 (actual)
• Sponsor: B. Braun Melsungen AG · Industry
• Sex: All
• Age: 50 Years – 80 Years
• Healthy volunteers: Not accepted

Summary

This investigational study will investigate two different volume replacement regimes in patients suffering from compromised renal function.

Conditions

• Renal Insufficiency

Interventions

Type	Name	Description
DRUG	HES 130/0.42 + electrolyte solution	Tetraspan 6% as colloid component combined with Sterofundin ISO as electrolyte component
DRUG	Albumin + electrolyte solution	Albumin 5% as colloid component and NaCl 0.9% as electrolyte component

Timeline

• Start date: 2009-11-01
• Primary completion: 2010-09-01
• Completion: 2010-09-01
• First posted: 2009-07-09
• Last updated: 2010-09-28

Locations

2 sites across 1 country: Germany